Product Information
ROZEREM 8 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.4424 per EA under NDC 64764080510. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the ramelteon market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764080510
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RAMELTEONApproval Type
New Drug (NDA)
FDA Application
NDA021782On Market Since
7/22/2005
Pharmacological Classes
Price Statistics
The NADAC for ROZEREM 8 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 83.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.4424 per EA |
|---|---|
| All-time high | $12.5063 (Aug 10, 2022) |
| All-time low | $6.7825 (Nov 28, 2013) |
| 52-week high | $12.4497 |
| 52-week low | $12.4069 |
| Median price | $12.3846 |
| Average price | $11.4325 |
| Largest weekly change | +9.9% (Apr 9, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROZEREM 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROZEREM 8 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.4424 per EA (NDC 64764080510), effective Jun 24, 2026.
How has the price of ROZEREM 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROZEREM 8 MG TABLET has risen 83.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROZEREM 8 MG TABLET?
Since Nov 28, 2013, the NADAC for ROZEREM 8 MG TABLET has ranged from a low of $6.7825 (Nov 28, 2013) to a high of $12.5063 (Aug 10, 2022), with a median of $12.3846 per EA.
Are there cheaper alternatives to ROZEREM 8 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROZEREM 8 MG TABLET, but none are currently priced below it.
Who manufactures ROZEREM 8 MG TABLET?
ROZEREM 8 MG TABLET (NDC 64764080510) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification